Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Stuart Cobb | Chief Scientific Officer | 2025-05-14 | 6,797 | $15.15 | $103.00kSell |
Christine Mikail Cvijic | President and CFO | 2025-03-13 | 4,501 | $16.94 | $76.25kSell |
Samsara Biocapital GP LLC | 10% Owner | 2024-11-26 | 20,748 | $24.91 | $516.83kBuy |
Samsara Biocapital GP LLC | 10% Owner | 2024-11-26 | 15,219 | $26.73 | $406.80kBuy |
Samsara Biocapital GP LLC | 10% Owner | 2024-11-26 | 10,803 | $26.01 | $280.99kBuy |
Samsara Biocapital GP LLC | 10% Owner | 2024-11-26 | 2,000 | $27.50 | $55.00kBuy |
Rachel McMinn | Chief Executive Officer | 2024-11-22 | 47,500 | $20.40 | $969.00kBuy |
Christine Mikail Cvijic | President and CFO | 2024-11-22 | 24,000 | $20.48 | $491.40kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Redmile Group LLC | 27.11% | 3,866,579 | $69.75M | Insider |
Jonathan G. Drachman | 16.12% | 2,298,686 | $41.47M | Insider |
Gary Bridger | 13.48% | 1,922,775 | $34.69M | Insider |
Samsara Biocapital LLC | 12.04% | 1,717,127 | $30.98M | Institution |
Samsara Biocapital GP LLC | 11.70% | 1,668,357 | $30.10M | Insider |
Ventures West 8 Limited Partnership | 10.83% | 1,543,989 | $27.85M | Insider |
Baker Bros Advisors LP | 10.42% | 1,486,200 | $26.81M | Institution |
Johnson Johnson | 10.11% | 1,442,094 | $26.02M | Insider |
Blackrock Inc | 9.81% | 1,399,133 | $25.24M | Institution |
Carl Walkey | 9.48% | 1,352,489 | $24.40M | Insider |